Kinase inhibitor
Nintedanib (brand name OFEV) is a medicine used to treat certain lung diseases that cause scarring, such as idiopathic pulmonary fibrosis (IPF) and other progressive lung diseases. It works by blocking specific enzymes (kinases) that contribute to the scarring process.
How it worksNintedanib is a kinase inhibitor that works by blocking signals in the body that lead to lung scarring.
Brand names:Ofev
How to take
The standard dose is 150 mg taken by mouth twice a day, about 12 hours apart, with food.
People with mild liver problems may need a lower dose of 100 mg twice daily. Always take this medicine with food.
Key warnings
- ·Liver health: Nintedanib can cause liver injury. Regular liver function tests are required.
- ·Pregnancy: This drug can cause harm to an unborn baby. Women of childbearing age should have a pregnancy test before starting treatment.
- ·Gastrointestinal issues: There is a risk of stomach or intestinal holes (perforation) and bleeding.
- ·Blood clots: There is a risk of serious blood vessel events.
Do not use if
- ·None listed
Side effects
Common
Serious
- ·Liver injury
- ·Blood clots (arterial thromboembolic events)
- ·Bleeding risk
- ·Gastrointestinal perforation (holes in the stomach or intestines)
- ·Kidney-related protein in urine
- ·Fetal harm
Seek help if
- ·Yellowing of skin or eyes
- ·Dark or tea-colored urine
- ·Severe stomach pain
- ·Easy bruising or bleeding
Interactions
- ·Medicines that block or speed up certain liver enzymes (like P-gp or CYP3A4 inhibitors/inducers) can change how much Nintedanib is in your body.
- ·Examples of drugs to watch out for include ketoconazole, erythromycin, rifampicin, carbamazepine, phenytoin, and St. John's wort.
Special populations
PregnancyNintedanib can cause serious harm or death to a fetus. If you are pregnant or planning to become pregnant, you must discuss the risks with your doctor.
PediatricThe safety and effectiveness of Nintedanib have not been proven in children. Studies in young people did not show it was effective for treating scarring lung diseases.
GeriatricNintedanib has been used in many older adults in clinical trials. No major differences in safety or effectiveness were found for people 65 or older compared to younger adults.
Talk to your doctor
Monitor
- ·Liver enzyme levels
- ·Pregnancy status
- ·Gastrointestinal symptoms
- ·Blood pressure
Questions to ask
- ·What are the risks to my liver while taking Nintedanib?
- ·How often will I need liver function tests?
- ·How should I manage diarrhea while on this medication?
- ·Are my other medications safe to take with OFEV?
Pharmacokinetics
Practical
OverdoseIf you take too much, stop the medicine and seek medical help for supportive care. Most reported cases of high doses resulted in side effects similar to normal use.
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.
